PLx Pharma Inc (PLXP) USD0.001
PLx Pharma Inc. is a pharmaceutical company. The Company is focused on its PLxGuard drug delivery platform. Its core product includes VAZALORE, available in two doses 325miligram (mg) and 81 mg, is a formulation of aspirin clinically shown to provide platelet inhibition for patients with vascular disease and diabetic patients who may be candidates for aspirin therapy. Its PLxGuard delivery system uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs with a targeted release to select portions of the GI tract. Its product pipeline also includes other oral non-steroidal anti-inflammatory drugs (NSAIDs) using the PLxGuard drug delivery platform, including PL1200 Ibuprofen 200 mg and PL1200 Ibuprofen 400 mg, for pain and inflammation in Phase I clinical stage.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.